Leading Clinical Image Data Broker Company Positioned for Growth
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–OneMedNet Corporation, a leader in the emerging field of data mining and monetization of imaging real world data, announced the addition of a new and substantive senior executive. Jon Freeman has joined the company as the Chief Financial Officer (CFO). He has over 25 years of finance, operations, and management experience spanning several industries including medical technology, industrial manufacturing, and professional services.
“We are fortunate to have Jon join our team. His experiential depth and diversity are noteworthy for our industry,” commented Mike LaChance, OneMedNet CEO. “Most importantly, Jon is well-recognized for creating considerable shareholder value throughout his career.”
Jon’s leadership experience in Healthcare/Life Sciences include progressive roles at: Fluke/Danaher, ev3/Covidien, Medafor (acquired by C.R. Bard), HistoSonics, and Gila Therapeutics. “This is a great opportunity to join a dynamic and innovative organization that is a well-positioned in a high growth segment,” stated Mr. Freeman.
About OneMedNet Corporation
OneMedNet Corporation provides innovative solutions that unlock the significant value contained within clinical image archives. The company’s initial flagship product, BEAM®, facilitates secure and rapid image exchange. Broadening innovations led to empowering Data Science with imaging. Serving both healthcare providers who are looking to capitalize on one of their largest assets (image archives), and life science companies who are in critical need of Real World Data, OneMedNet provides a unique Data Broker solution to meet the needs.
Contacts
OneMedNet Contact: Del Coufal, del.coufal@onemednet.com, (800-918-7189)
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…
CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…
MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…
